Action Center

Support And Value Expectant Moms and Babies Act - H.R. 554

This bill would:

  • prohibit the approval of new abortion drugs;
  • prevent the dispensing of abortion drugs remotely, by mail, or via tele-medicine; and
  • impose additional regulatory requirements with respect to previously approved abortion drugs.
  • In 2017, chemical abortions made up 39 percent of abortions reported by the 32 states that require reporting on specific abortion methods, up from 5.5 percent in 2001.
  • Lifting the Risk Evaluation and Mitigation Strategies (REMS) currently applied to abortion drugs (due to known or potential serious risks) and making chemical abortion available by prescription endangers women and would effectively override most state pro-life protections like parental involvement, waiting periods, and informed consent.
  • U.S. Supreme Court ruling allows the FDA to enforce in-person requirements for the abortion pill under Mifeprex’s REMS.
    Message Body
    Suggested Message
    Remaining: 0
  • Hide
    • Please call this number:

      Please do not close this window. You will need to come back to this window to enter your code.
      We just sent an email to ... containing a verification code.

      If you do not see the email within the next five minutes, please ensure you entered the correct email address and check your spam/junk mail folder.
      Enter Your Info
      Your Information
      Check if you are a health professional:
      Home Information

      Enter Your Info